menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Desvenlafaxine: The Newest Antidepressant

Program Information
Recommended
Desvenlafaxine:  The Newest Antidepressant
RestartResume
After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do y...
  • Overview

    After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth Pharmaceuticals to discuss the ins and outs of desvenlafaxine.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/20/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.